Abbott to Hike Production of Lower-Cost Glucose Monitors as Diabetes Soars

By Reuters
NYT Business Day
Abbott Laboratories plans to ramp up manufacturing capacity for its lower-cost continuous glucose monitor, the FreeStyle Libre, by three to five times in the next few years, aiming to reach millions more patients worldwide, the company told Reuter...
Published date: July 16, 2019 at 01:30PM
Reuters
New York Times article